Table 3 Depression and anxiety scores among cases and control
From: Sleep quality among psoriasis patients: excluding the immunosuppressive therapy effect
| Â | Cases | Controls | P value | ||||
Mean | S.D | Mean | S.D | ||||
BDI | 20.93 | 10.75 | 3.48 | 3.42 | < 0.001 | ||
Taylor Manifest Anxiety Scale | 24.65 | 8.71 | 6.40 | 5.78 | < 0.001 | ||
| Â | Cases | Controls | Pvalue | ||||
Count | % | Count | % | ||||
Beck Depression Inventory | Normal | 20 | 20.0% | 72 | 90.0% | < 0.001 | |
Mild | 15 | 15.0% | 8 | 10.0% | |||
Borderline | 19 | 19.0% | 0 | 0.0% | |||
Moderate | 28 | 28.0% | 0 | 0.0% | |||
Severe depression | 13 | 13.0% | 0 | 0.0% | |||
Extreme | 5 | 5.0% | 0 | 0.0% | |||
| Â | Cases | Controls | Pvalue | ||||
Count | % | Count | % | ||||
Taylor Manifest Anxiety Scale | No anxiety | 18 | 18.0% | 72 | 90.0% | < 0.001 | |
Mild anxiety | 21 | 21.0% | 8 | 10.0% | |||
Moderate anxiety | 20 | 20.0% | 0 | 0.0% | |||
Severe anxiety | 11 | 11.0% | 0 | 0.0% | |||
Extreme anxiety | 30 | 30.0% | 0 | 0.0% | |||